HSE club

Dialysis patients need to be vaccinated against new coronary pneumonia

By: HSE Jul. 10,2021
Since mid-May, the local NCCP epidemic has been spreading, but fortunately, the vaccine has been available to provide priority vaccination to eligible people.

Thanks to the active efforts and appeals of the Taiwan Society of Nephrologists, the Department of Disease Control and Prevention of the Ministry of Health and Welfare has reclassified the NCCP vaccine for dialysis patients from Category 8 (elderly aged 65-74) or Category 9 (patients with major injuries) to Category 5, and the vaccine will be available after June 15.

During recent dialysis visits, many kidney patients or family members ask, "Are dialysis patients so weak that they are suitable for vaccination? Will there be any side effects?

Kidney patients are susceptible to Wuchereria pneumonia

Patients on dialysis have poor resistance and are more susceptible to infection by the New Coronavirus than the general population; they also need to go to medical institutions frequently (three times a week, 52 weeks a year, or 156 times) to receive regular hemodialysis treatment, which increases the risk of infection.

Renal patients often have multiple co-morbidities and serious systemic diseases, and are 5 to 16 times more likely to get COVID-19 than the general population.

Once infected, there is a very high risk of becoming seriously ill and requiring hospitalization, and the death rate is 3.6 times higher than that of the general population.

According to the UK database, the mortality rate of dialysis patients with COVID-19 compared to the general population of the same age group is shown below by age range.

The risk of death in kidney patients over 60 years of age is 10 times or even 30 times higher than that in the general population of the same age group; in younger dialysis patients, the risk of death is nearly 100 times or even 400 times higher than that in the general population of the same age group!

Why do young kidney patients have a much higher risk of death after infection than older kidney patients in the same age range?

Overseas studies and recent local experience have found that the new coronary pneumonia virus is particularly lethal to the elderly, and once infected, the rate of serious illness is high, resulting in death or injury. In contrast, young people in good health with no specific diseases have a better prognosis even if they are infected with the virus!

However, dialysis patients have poor resistance and are easily infected; once infected, even young kidney patients have a much higher risk of becoming seriously ill or even dying than the general public.

Therefore, when comparing dialysis patients of the same age group, the younger the patient, the higher the risk of death from the disease than the general population of the same age group.

Pros and cons of the new crown vaccine

As we know from the experience of European and American countries, apart from wearing masks, washing hands frequently, keeping social distance, and reducing the chance of gathering in groups, vaccination against Neoconiosis is the only solution to effectively reduce the rate of infection and mortality.

Many medical studies have pointed out that vaccination against NCC can effectively reduce the chance of being infected by the virus; even if the disease is still contracted after vaccination, the symptoms are usually mild, just like the common cold.

Clinical data published by AZ (AstraZeneca), Moderna, Pfizer-BioNTech, and Johnson & Johnson vaccines all show that no one who has received the vaccine has been hospitalized or infected with COVID-19. COVID-19 has not resulted in hospitalization or death!


This is the greatest value of the vaccine. We don't want to be absolutely immune to the virus after the vaccine, but as long as we can help people survive with mild symptoms without hospitalization and help end the epidemic, that is the best vaccine!

Vaccination with the new crown vaccine protects patients with chronic diseases from infection and effectively reduces the chance of severe illness.

The vaccine may cause fever and chills, fatigue, pain and swelling at the vaccination site, headache, joint pain, muscle pain, etc. Generally speaking, it occurs less frequently in older people than in younger people. Even if there is really discomfort, it will usually be relieved within a day or two.

The two days of discomfort in exchange for avoiding getting a new pneumonia serious illness, Dr. Zhang thinks it is a very good investment!

Adverse reactions to vaccines are scary, should I get them?

After the recent expansion of the COVID-19 vaccine, there were many conversations with patients' families about whether or not they should get the vaccine.

People are just worried about the possibility of blood clots caused by the AZ vaccine, especially with the media's extensive coverage, which makes people feel that the chance of adverse reactions to the vaccine is very high!

The side effects of the vaccine are so scary, should we get it or not?

In the face of this problem, we should return to rational analysis and let the statistics speak for themselves!

According to Dr. Tsai Chin-sang of the Department of Infectious Diseases at National Cheng Kung University Hospital, the incidence of blood clots and platelet depression after AZ vaccination is 10 in a million, while pregnancy also increases the risk of blood clots, with an incidence rate of more than 760 in a million.

However, pregnancy also increases the risk of blood clots, with an incidence rate of more than 760 parts per million. In comparison, the risk of getting a blood clot during pregnancy is much higher than the AZ vaccine!

If your attitude towards "pregnancy can cause blood clots" is: "The chance of that happening is very low, there are so many people around you who are pregnant, I haven't heard of anyone having blood clots.

If you are still worried about blood clots and feel hesitant about getting the AZ vaccine, you can also take a look at the pros and cons comparison from the Winton Centre for Risk and Evidence Communication in the UK.

As you can see from the chart above.

1. the higher the prevalence of NCCP, the greater the benefit of vaccination (avoidance of critical intubation) over the risk of thrombosis after vaccination.
The protective benefits of the vaccine are significantly higher in the older age group (60-69 years)!

Within 28 days after vaccination, one should be highly alert for symptoms such as persistent headache, abdominal pain, unilateral foot swelling, or chest pain and difficulty breathing.

The National Institutes of Health Dr. Guo Shu-chen pointed out that in the United States, the rate of death due to new pneumonia infection without vaccination is 915 per million.


As for the Modena and Pfizer vaccines, which many people are waiting for, although no blood clots have been reported, they may cause facial nerve paralysis (Modena: 198 parts per million, Pfizer: 105 parts per million) or myocarditis (according to the U.S. CDC, mainly in male adolescents and young people over 16 years of age), so if you have the opportunity to receive them later, you should pay close attention to whether or not If you have the chance to get it later, you should pay close attention to whether you have any related discomfort.

Besides dialysis, I have a certain disease, can I get it?

In addition to dialysis patients who are susceptible to NCCP infection and are likely to become seriously ill once infected, chronic kidney disease, diabetes, cardiovascular disease and organ transplant patients have a higher risk of death after contracting WCHP than the general population.

If there is a waiting list for the publicly funded NCC vaccine, the following groups are highly encouraged to receive the vaccine as soon as possible to obtain early protection according to the recommendations of the medical societies or professional teams at the medical centers.

For more information, please refer to my article: Can I get the vaccine if I have a certain disease?


As the old adage goes, there is no such thing as the best vaccine.

However, considering the many complications and even deaths associated with COVID-19 infection, the protective benefits of the Neocon vaccine far outweigh the incidence of adverse reactions to the vaccine, and governments and medical societies recommend that eligible people, including dialysis patients, be vaccinated.

The best vaccine is the one you can get now!
Disclaimer: The pictures are from the Internet,
if there is any infringement, please contact to delete.
Related tags
Related articles